MADRIGAL PRESENTS, Resmetirom a leade... - Living with Fatty...

Living with Fatty Liver and NASH

8,327 members2,180 posts

MADRIGAL PRESENTS, Resmetirom a leader in NAFLD/NASH drug development

nash2 profile image
nash2Partner
3 Replies

Resmetirom is one of only two drugs in the pipeline focused on thyroid hormone functions and having good success. Now in a phase 3 trial.

fattyliverfoundation.org/ma...

Written by
nash2 profile image
nash2
Partner
To view profiles and participate in discussions please or .
3 Replies
Cats2018 profile image
Cats2018

Hi Wayne - Loved reading your post. I’m currently in the year long Madrigal Pharmaceuticals phase 3 clinical trial of Resmetirom! I started in the trial October 2020. Of course I don’t know if I’m on placebo or the Resmetirom. I just replied to your email about this a little earlier today. I’m excited about this trial. My next appointment in July is week 40 so I’m over half way through.

Char

lecc profile image
lecc

Thanks for sharing Wayne. It is really nice knowing that NAFLD/NASH drug development is an active research field :)

Robboref profile image
Robboref

Hi. Just to say that I am now on that trial. Been on the tablets now for 2 months so a long way to go.Robbo

Not what you're looking for?

You may also like...

Madrigal drug Resmetirom approved by FDA

https://www.fattyliverfoundation.org/a_new_dawn_in_liver_health_fatty_liver_foundation_applauds_brea
nash2 profile image
Partner

The State of NAFLD/NASH Care in America 2023 is Live - We Need Your Voice

Hi community members,  Last year, many of you generously took the time to share your patient...
AfternoonCoffee profile image
Administrator

I need help from a few NAFLD/NASH patients who are willing to tell their stories and perhaps participate in a panel discussion.

I think you probably know that Madrigal is likely to have the first drug approved to treat...
nash2 profile image
Partner

Will you take 90 Seconds to Help Improve healthcare for people with NAFLD/NASH? A note from Wayne

First of all, let me thank you in advance for taking this short survey. This may help the patient...
nash2 profile image
Partner

The New NAFLD/NASH guidance is out but how do we use it as patients? Here is an explanation and a suggestion from the Fatty Liver Foundation

The new guidance for managing NAFLD/NASH has been officially published. This is the official...
nash2 profile image
Partner